User login

We offer our registered users tailored information, free online courses and exclusive content.

You have an old EXCEMED account ...

Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?

... or you lost your password?

Scientific highlights: Diabetes and Thyroid disorders in clinical practice today

Scientific highlights: Diabetes and Thyroid disorders in clinical practice today
  • Endocrinology and metabolism
  • Diabetes
    Thyroid disorder

Resource type



medical communications
thyroid cancer

St Petersburg, Russia was the venue for the annual meeting ‘Diabetes and Thyroid disorders in clinical practice today’ on 25 April 2015. The subject was particularly relevant with rising levels of diabetes and thyroid diseases and interest in their clinical management in this region and in many developing countries. As a result, more than 200 people attended the meeting, ranging from endocrinologists and diabetologists to general practitioners coming from many eastern countries.

The meeting focused on particular clinical aspects of thyroid diseases and diabetes with international speakers giving the latest data based on international guidelines and standards of care and on their own clinical experience and field of research.

Prof. Mahmoud Ibrahim stressed the importance of a screening program to identify patients with pre diabetes in at risk groups, before they develop macro and microvascular complications.

Prof. Pozzilli, presenting on the association of type 2 Diabetes, obesity and metabolic syndrome showed how the understanding of the interplay of pathological mechanisms involving multiple organs can help produce a strategy for managing complex diseases such as diabetes.  

Prof. Buzzetti described the principle features of the clinical diabetes phenomenon known as Latent Autoimmune Diabetes in Adults (LADA). In such instances correct diagnosis and treatment is essential to achieve a successful outcome.

In the field of thyroid a presentation from Prof. Salman Razvi discussed the clinical consequences, particularly cardiovascular disease, of subclinical hypothyroidism and the value of pharmacological treatment in a range of age groups. 

Prof. Bernadette Biondi spoke on cardiovascular involvement associated with subclinical and overt autoimmune hyperthyroidism that could be linked to the excess of thyroid hormones but also potentially to a specific autoimmunity, focusing on the importance of a prompt diagnosis and treatment of cardiac manifestations in hyperthyroidism.

Data on the clinical association of type 1 diabetes , autoimmune thyroid disease and other autoimmune endocrine and non-endocrine diseases was provided by Prof. George Kahaly  who described several clinical aspects of such diseases and presented a practical algorithm for the screening and follow up of patients affected by autoimmune diseases.

Prof. Roberto Nigro explained the complications linked to thyroid diseases during pregnancy, both hypo and hyperthyroidism, which lead to an increased risk of maternal and neonatal complications, giving some practical clinical evidence -based guidelines for the pharmacological treatment of both hypo and hyperthyroidism.

Prof. Andreas Kopp gave a thorough analysis of the recent international guidelines for treatment of thyroid cancer. He raised some interesting clinical aspects, such as an ultrasound stratification model for the indication of fine needle aspiration and some details on cytology and molecular markers, as well as some indications on treatment, radioiodine ablation and innovative therapy for patients with advanced metastatic cancer.

Finally Dr. Daniel Schmid gave some key points on the importance for physicians of improving medical communication skills, in managing chronic disease where compliance to treatment and understanding of the disease is crucial for a positive outcome of care. He focused on the importance of understanding patient knowledge of the disease affecting them and their perspective – the first steps to positive, effective communication between patient and clinician.

Terms of use

This is a copyrighted resource for the sole purpose of education. Resource may be used for classroom training only and must remain as is, including the branding and EXCEMED logo. It is backed by a publishing license, signed by the author.

Regional conference
St. Petersburg, Russia
Apr 25, 2015
Target audience
Endocrinologists, diabetologists, Healthcare professionals
by Excemed
Cardiometabolic, Endocrinology and metabolism